# Buprenorphine as a Treatment in Opiate Dependent Pain Patients

> **NCT00552578** · PHASE4 · TERMINATED · sponsor: **State University of New York at Buffalo** · enrollment: 12 (actual)

## Conditions studied

- Opiate Addiction
- Refractory Pain

## Interventions

- **DRUG:** buprenorphine/naloxone
- **DRUG:** buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT00552578
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** "Tapering doses" protocol arm was not effective for treatment retention outcome.
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00552578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00552578, "Buprenorphine as a Treatment in Opiate Dependent Pain Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00552578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
